GENinCode Advances CHD Risk Prediction

GENinCode UK Ltd. (GB:GENI) has released an update.

GENinCode UK Ltd. presented new findings at the European Society of Cardiology Congress, demonstrating that CARDIO inCode-Score® can predict coronary heart disease (CHD) risk by considering both genetic factors and family history. The study showed a significant increase in CHD risk with a high polygenic risk score and positive family history, emphasizing the need for a comprehensive approach to preventive care. The company’s technology aims to enhance patient risk assessment, facilitating earlier and more effective interventions for those at high genetic risk of CHD.

For further insights into GB:GENI stock, check out TipRanks’ Stock Analysis page.